摘要
由于肾脏移植手术技巧的改进及新型免疫抑制剂和免疫抑制方案的进展,移植肾的近期生存率与长期生存率均有很大的提高,但肾移植至今仍面临许多亟待解决的困难。肾移植受者因其特殊性,发生急性肾衰竭(ARF)的可能性远高于一般人群。移植后早期的基础肾功能对移植肾长期生存有重要影响,故移植肾ARF的救治成功与否成为影响移植肾长期生存的突出问题。
出处
《中华内科杂志》
CAS
CSCD
北大核心
2007年第1期13-15,共3页
Chinese Journal of Internal Medicine
参考文献4
-
1吴建永,陈江华,王逸民,张建国,朱琮,王苏娅,张萍,黄洪锋,何强.完全逆转的急性排斥对移植肾长期生存率的影响[J].中华医学杂志,2003,83(2):106-109. 被引量:11
-
2陈江华,吕蓉,陈莹,吴建永,何强,黄洪锋,瞿立辉.肾移植受者术前血清可溶性CD30水平与受者及移植物长期存活的关系[J].中华医学杂志,2005,85(22):1560-1563. 被引量:13
-
3黄洪锋,陈江华,吴建永,王逸民,张建国,袁静.肾移植患者术前群体反应性抗体监测及处理[J].中华肾脏病杂志,2002,18(5):371-372. 被引量:6
-
4陈江华,茅幼英,何强,吴建永,吕蓉.术前巨细胞病毒感染对移植肾急性排斥的影响[J].中华肾脏病杂志,2005,21(4):223-226. 被引量:9
二级参考文献44
-
1Becker BN, Becker YT, Leverson GE, et al. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation. Am J Kidney Dis, 2002,39: 1088-1095.
-
2Landolfo S, Gariglio M, Gribaudo G, et al. The human cytomegalovirus. Pharmacol Ther, 2003,98: 269-297.
-
3Cainelli F, Vento S. Infections and solid organ transplant rejection: a cause-and-effect relationship? Lancet Infect Dis,2002,2: 539-549.
-
4Kim CK, Song JH, Kim SM, et al. Clinical usefulness of human cytomegalovirus antigenemia assay after kidney transplantation. Transplantation, 2003,75: 2151-2155.
-
5Lee W,Tsang WK,Tong KL,et al. Cytomegalovirus infection and graft rejection in renal transplantation: a single-center experience. Transplant Proc,2003, 35: 282-283.
-
6Dickenmann M J, Cathomas G, Steiger J, et al. Cytomegalovirusinfection and graft rejection in renal transplantation.Transplantation, 2001,71: 764-767.
-
7Sageda S, Nordal KP, Hartmann A, et al. The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients. Am J Transplant, 2002,2: 850-856.
-
8McLaughlin K, Wu C, Fick G, et al. Cytomegalovirus seromismatching increases the risk of acute renal allograft rejection. Transplantation, 2002,74: 813-816.
-
9Fitzgerald JT,Gallay B,Taranto SE,et al. Pretransplant recipient cytomegalovirus seropositivity and hemodialysis are associated with decreased renal allograft and patient survival.Transplantation, 2004,77: 1405-1411.
-
10Sagedal S,Nordal KP,Hartmann A,et al. Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir:a randomized, comparative study. Nephrol Dial Transplant, 2003,18: 1899-1908.
共引文献30
-
1陈江华,王仁定,吴建永,王逸民,朱琮,张建国.肾移植术后6个月血清肌酐水平对移植肾长期存活的影响[J].中华肾脏病杂志,2004,20(3):206-209. 被引量:4
-
2陈江华,王仁定,吴建永,王逸民,朱琮,张建国,王苏娅,张萍,黄洪锋,何强.移植肾早期血管性排斥对晚期排斥发生的影响[J].中华医学杂志,2005,85(5):332-334. 被引量:4
-
3黄洪锋,陈江华,吴建永,王逸民,张建国,彭文翰.双滤过法血浆分离联合达昔单抗预处理肾移植致敏受者的临床效果[J].中华泌尿外科杂志,2005,26(2):97-100. 被引量:5
-
4陈江华,吕蓉,何强,田炯,王慧萍,金娟,陈莹,茅幼英.肾移植受者术前血清可溶性CD30水平对急性排斥的影响[J].中华肾脏病杂志,2005,21(8):487-490. 被引量:4
-
5梁廷波,俞志勇,郑树森.非T细胞来源细胞因子在小鼠心脏移植急性排斥反应模型中的表达[J].中华医学杂志,2006,86(1):26-30. 被引量:3
-
6梁思敏,苟欣.术前巨细胞病毒感染对肾移植的影响[J].第三军医大学学报,2006,28(10):1101-1103. 被引量:2
-
7王平贤,黄赤兵,范明齐,张艮甫.肾移植患者活动性巨细胞病毒感染临床研究[J].重庆医学,2006,35(15):1352-1354. 被引量:1
-
8余玉明,于立新,刘艳君,邓文锋.肾移植术后早期天然免疫分子Toll样受体4动态变化的规律[J].中华医学杂志,2007,87(32):2238-2240. 被引量:3
-
9毕永春,张葵.CD30基因多态性与慢性肾功能衰竭及肾移植术后急性移植排斥反应的相关性[J].中国组织工程研究与临床康复,2007,11(43):8633-8636. 被引量:1
-
10陈江华.移植肾急性排斥的新认识[J].诊断学理论与实践,2007,6(6):494-498. 被引量:2
同被引文献15
-
1华梓婷,郭养浩,孟春,刘晓楠.细胞色素P450的基因多态性与药物代谢[J].中国新药杂志,2007,16(7):510-515. 被引量:21
-
2Segall L,Covic A.Diagnosis of tuberculosis in dialysis patients:current strategy.Clin J Am Soc Nephrol,2010,5:1114-1122.
-
3Richardson RM.The diagnosis of tuberculosis in dialysis patients.Semin Dial,2012,25:419-422.
-
4Agarwal R,Nissenson AR,Batlle D,et al.Prevalence,treatment,and control of hypertension in chronic hemodialysis patients in the United States.Am J Med,2003,115:291-297.
-
5K/DOQI Workgroup.K/DOQI clinical practice guidelines forcardiovascular disease in dialysis patients.Am J Kidney Dis,2005,45:S1-153.
-
6Davenport A,Cox C,Thuraisingham R.Achieving blood pressuretargets during dialysis improves control but increases intradialytic hypotension.Kidney Int,2008,73:759-764.
-
7H(o)rl MP,H(o)rl WH.Hemodialysis-associated hypertension:pathophysiology and therapy.Am J Kidney Dis,2002,39:227-244.
-
8Laurent G.How to keep the dialysis patients normotensive? What is the secret of Tassin?.Nephrol Dial Transplant,1997,12.
-
9Niemi M,Backman JT,Fromm MF,et al.Pharmacokinetic interactions with rifampicin:clinical relevance.Clin Pharmacokinet,2003,42:819-850.
-
10Wilkinson GR.Drug metabolism and variability among patients in drug response.N Engl J Med,2005,352:2211-2221.
二级引证文献3
-
1赵洪.小剂量激素联合他克莫司对局灶节段性肾小球硬化并发早期肾衰竭疗效研究[J].中国卫生标准管理,2016,7(20):90-91. 被引量:2
-
2聂琴琪,王婉洁,曲令芝.中药皮肤透析温度调适护理对慢性肾功能衰竭皮肤瘙痒患者的影响[J].中国临床护理,2019,11(5):369-372. 被引量:5
-
3徐月霞,凌凯,李红艳,刘蔚.MHD对慢性肾衰患者血清PTH、β2-Mg水平及机体营养状况的影响分析[J].河北医药,2020,42(7):1068-1071. 被引量:9
-
1毕旭东,张红,付晓光.胆道再次手术原因及治疗对策[J].中国中西医结合外科杂志,2003,9(1):23-24. 被引量:1
-
2刘宁,林爱龙,程新富,钱晟.重型颅脑损伤44例救治分析[J].人民军医,2014,57(6):670-671.
-
3何晓顺,巫林伟,鞠卫强,邰强,韩明,王东平,朱晓峰,黄洁夫.四种不同肝移植手术方式的选择[J].中国医学科学院学报,2008,30(4):426-429. 被引量:4
-
4孙辉,臧学慧,高立华,谭永滔.不同方式治疗老年转子间粉碎骨折患者的近期生存率及相关影响因素[J].中国老年学杂志,2015,35(15):4298-4300. 被引量:3
-
5张鹏,沈忆新.老年腰椎管狭窄症的诊疗[J].中华临床医师杂志(电子版),2013,7(19):16-17. 被引量:3
-
6瞿立辉,吕蓉,吴建永,王逸民,张萍,陈江华.肾移植术后早期急性肾功能损害救治及存活率临床分析[J].中华肾脏病杂志,2009,25(5):392-393. 被引量:2
-
7汪国营,陈规划.新的非侵入性生物标志物microRNA在器官移植中的应用研究[J].器官移植,2013,4(2):107-112.
-
8罗炳杰.医源性胆管损伤的防治[J].中国误诊学杂志,2001,1(11):1748-1750.
-
9白延霖,郭亚民,安永德.医源性肝外胆管损伤14例分析[J].肝胆外科杂志,2001,9(4):299-300. 被引量:2
-
10张微,胡伟,曾文高,唐荣华,唐洲平,雷霆.微创血肿清除术治疗脑出血患者近期生存率及颅外并发症研究[J].中华实验外科杂志,2009,26(9):1210-1211. 被引量:20